PHF8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.52017999999199E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.50480000016273E-07 |
Normal-vs-Stage2 |
2.483200E-01 |
Normal-vs-Stage3 |
7.828500E-02 |
Normal-vs-Stage4 |
5.977700E-03 |
Stage1-vs-Stage2 |
1.945830E-01 |
Stage1-vs-Stage3 |
7.716100E-02 |
Stage1-vs-Stage4 |
6.342000E-01 |
Stage2-vs-Stage3 |
9.263600E-01 |
Stage2-vs-Stage4 |
4.329400E-01 |
Stage3-vs-Stage4 |
4.541200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.36749999996222E-06 |
Normal-vs-AfricanAmerican |
2.786600E-04 |
Normal-vs-Asian |
3.582400E-02 |
Caucasian-vs-AfricanAmerican |
9.568000E-01 |
Caucasian-vs-Asian |
8.766400E-01 |
AfricanAmerican-vs-Asian |
9.034400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.97889999997702E-06 |
Normal-vs-Female |
4.274400E-02 |
Male-vs-Female |
6.781200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.10250000000078E-05 |
Normal-vs-Extreme_Weight |
1.89390000004952E-06 |
Normal-vs-Obese |
1.361190E-03 |
Normal-vs-Extreme_Obese |
2.390400E-04 |
Normal_Weight-vs-Extreme_Weight |
7.328600E-01 |
Normal_Weight-vs-Obese |
2.557000E-01 |
Normal_Weight-vs-Extreme_Obese |
6.417200E-01 |
Extreme_Weight-vs-Obese |
9.832200E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.079000E-01 |
Obese-vs-Extreme_Obese |
2.747600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.242200E-01 |
Normal-vs-Age(41-60Yrs) |
1.541380E-03 |
Normal-vs-Age(61-80Yrs) |
2.74519999954315E-07 |
Normal-vs-Age(81-100Yrs) |
1.632080E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.750400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.607940E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.032000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.934010E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.208200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.715600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.24590000003278E-06 |
Normal-VS-Type2 PRCC |
1.75976999999827E-05 |
Normal-VS-KIRP CIMP |
6.761600E-01 |
Normal-VS-Unclassified PRCC |
1.183760E-02 |
Type1 PRCC-VS-Type2 PRCC |
3.504800E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.814200E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.093400E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.294200E-02 |
Type2 PRCC-VS-Unclassified PRCC |
1.040410E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.645990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.98979999999472E-05 |
Normal-vs-N1 |
4.433600E-01 |
Normal-vs-N2 |
8.475800E-01 |
N0-vs-N1 |
2.226000E-02 |
N0-vs-N2 |
1.317980E-01 |
N1-vs-N2 |
8.309800E-01 |
|
|